Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) and Cocrystal Pharma (NASDAQ:COCP – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Insider & Institutional Ownership 86.2% of Milestone […]
HC Wainwright restated their buy rating on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Free Report) in a research report released on Friday, Benzinga reports. The brokerage currently has a $25.00 price objective on the stock. Several other equities analysts have also issued reports on the company. Piper Sandler reduced their price target on Milestone Pharmaceuticals […]
Milestone Pharmaceuticals (NASDAQ:MIST – Free Report) had its price target decreased by TD Cowen from $17.00 to $9.00 in a research report released on Wednesday, Benzinga reports. TD Cowen currently has an outperform rating on the stock. Milestone Pharmaceuticals Stock Down 5.6 % Shares of NASDAQ MIST opened at $1.67 on Wednesday. Milestone Pharmaceuticals has […]
Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) and Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Profitability This table compares Milestone Pharmaceuticals and Madrigal […]
Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Free Report) – Investment analysts at HC Wainwright dropped their FY2025 earnings per share (EPS) estimates for shares of Milestone Pharmaceuticals in a research report issued to clients and investors on Monday, August 14th. HC Wainwright analyst P. Trucchio now expects that the company will earn $0.05 per share for […]